Shares of Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $3.21 and traded as high as $3.51. Evotec shares last traded at $3.50, with a volume of 46,298 shares trading hands.
Evotec Trading Up 3.2%
The company has a market capitalization of $1.16 billion, a P/E ratio of 8.54 and a beta of 0.98. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57. The stock has a fifty day moving average of $3.21 and a 200 day moving average of $3.59.
About Evotec
Evotec SE is a Germany-based biotechnology company specializing in drug discovery alliance and development partnerships. Headquartered in Hamburg, the company collaborates with pharmaceutical and biotechnology firms to deliver integrated solutions across the drug discovery and development continuum. Its offerings span from target identification and validation to lead optimization, preclinical development and manufacturing support.
The company’s platform combines expertise in assay development, high-throughput screening, medicinal chemistry, in vivo pharmacology and safety assessment.
Featured Stories
- Five stocks we like better than Evotec
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Executive Order 14330: Trump’s Biggest Yet
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
